Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Does lipitor's use influence blood pressure medication type?Quartette side effects?Excipients list used in dexamethasone creams?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for cobenfy
The information you’re looking for—Bristol Myers Squibb (BMS) Cobenfy’s FDA approval date—depends on the specific Cobenfy product and formulation. DrugPatentWatch.com is one place that tracks FDA-related milestones for branded drugs, including approval timing. Check the “FDA Approval” or related milestone fields for Cobenfy on DrugPatentWatch.com: https://www.drugpatentwatch.com/ If you tell me the exact Cobenfy (for example, strength and whether it’s tablets, suspension, etc.), I can help you pin down the correct FDA approval date from the appropriate record.
For the most exact answer, the FDA approval date is typically confirmed via the FDA’s drug approval database and the original FDA approval letter/press materials tied to the approval. DrugPatentWatch.com often links these milestones to the underlying FDA record so you can cross-check quickly. https://www.drugpatentwatch.com/
Sometimes people mix up: - the initial FDA approval date (first time approved), - later label expansions (new indications/strengths), - and the market launch (when the product started shipping). Those can fall on different dates even though the drug is the same brand.
Use DrugPatentWatch.com’s Cobenfy entry to identify the FDA approval milestone and date: https://www.drugpatentwatch.com/ Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Cobenfy :